341 related articles for article (PubMed ID: 2469867)
1. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
Waldman SA; Murad F
J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
[TBL] [Abstract][Full Text] [Related]
2. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
Rapoport RM; Murad F
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
[TBL] [Abstract][Full Text] [Related]
6. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
7. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
[TBL] [Abstract][Full Text] [Related]
8. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
9. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
[TBL] [Abstract][Full Text] [Related]
10. Role of cyclic-GMP in relaxations of vascular smooth muscle.
Murad F; Rapoport RM; Fiscus R
J Cardiovasc Pharmacol; 1985; 7 Suppl 3():S111-8. PubMed ID: 2409383
[TBL] [Abstract][Full Text] [Related]
11. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
Gruetter CA; Barry BK; McNamara DB; Gruetter DY; Kadowitz PJ; Ignarro L
J Cyclic Nucleotide Res; 1979; 5(3):211-24. PubMed ID: 39089
[TBL] [Abstract][Full Text] [Related]
12. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
Förstermann U
Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
[TBL] [Abstract][Full Text] [Related]
13. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
Kanamaru K; Waga S; Kojima T; Fujimoto K
No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
[TBL] [Abstract][Full Text] [Related]
14. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.
Rapoport RM; Murad F
Eur J Pharmacol; 1984 Sep; 104(1-2):61-70. PubMed ID: 6149944
[TBL] [Abstract][Full Text] [Related]
18. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
Buhimschi IA; San Martin-Clark O; Aguan K; Thompson LP; Weiner CP
Am J Obstet Gynecol; 2000 Dec; 183(6):1512-9. PubMed ID: 11120520
[TBL] [Abstract][Full Text] [Related]
19. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
20. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
Ruiz E; Del Rio M; Somoza B; Ganado P; Sanz M; Tejerina T
J Pharmacol Exp Ther; 1999 Jul; 290(1):310-3. PubMed ID: 10381792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
